A phase 0 study testing intralesional injection of ex-vivo expanded allogeneic universal donor (UD) NK and TGFβi NK cells in patients with cutaneous keratinocyte carcinomas

被引：0
|
作者：
Johnson, K. M. [1 ]
Lee, D. A. [2 ]
Dulmage, B. [1 ]
机构：
[1] Ohio State Univ, Dermatol, Columbus, OH USA
[2] Nationwide Childrens Hosp, Hematol Oncol, Columbus, OH USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2024年 / 144卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
768
引用
收藏
页码：S134 / S134
页数：1
相关论文
共 18 条
  • [1] Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a Phase I clinical study
    Barkholt, L.
    Alici, E.
    Conrad, R.
    Sutlu, T.
    Gilljam, M.
    Stellan, B.
    Christensson, B.
    Guven, H.
    Bjorkstrom, N. K.
    Soderdahl, G.
    Cederlund, K.
    Kimby, E.
    Aschan, J.
    Ringden, O.
    Ljunggren, H-G
    Dilber, M. S.
    IMMUNOTHERAPY, 2009, 1 (05) : 753 - 764
  • [2] A Phase I Trial of Adoptively Transferred Ex-Vivo Expanded Autologous Natural Killer (NK) Cells Following Treatment with Bortezomib to Sensitize Tumors to NK Cell Cytotoxicity
    Reger, Robert N.
    Berg, Maria
    Lundqvist, Andreas
    Donohue, Theresa
    Carlsten, Mattias
    Betters, Dawn M.
    Cook, Lisa
    Ramos, Catalina
    Grasmeder, Sophia
    Su, Su
    Stroncek, David
    Pantin, Jeremy
    Keyvanfar, Keyvan
    Carvallo, Cristian A.
    Khuu, Hahn
    Childs, Richard
    BLOOD, 2011, 118 (21) : 457 - 458
  • [3] Intraperitoneal infusion of ex vivo-cultured allogeneic NK cells in recurrent ovarian carcinoma patients (a phase I study)
    Hoogstad-van Evert, Janneke
    Bekkers, Ruud
    Ottevanger, Nelleke
    Schaap, Nicolaas
    Hobo, Willemijn
    Jansen, Joop H.
    Massuger, Leon
    Dolstra, Harry
    MEDICINE, 2019, 98 (05)
  • [4] Preliminary experience of ex-vivo expanded allogeneic universal donor TGFbi NK cell infusions in combination with irinotecan, temozolomide, and dinutuximab in patients with relapsed or refractory neuroblastoma: The Allo - STING trial
    Ranalli, Mark A.
    Shah, Nilay
    Skeens, Micah
    Streby, Keri A.
    Lamb, Margaret
    Cole, Lindsay A.
    Lee, Dean Anthony
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma
    Khatua, Soumen
    Cooper, Laurence J. N.
    Sandberg, David, I
    Ketonen, Leena
    Johnson, Jason M.
    Rytting, Michael E.
    Liu, Diane D.
    Meador, Heather
    Trikha, Prashant
    Nakkula, Robin J.
    Behbehani, Gregory K.
    Ragoonanan, Dristhi
    Gupta, Sumit
    Kotrotsou, Aikaterini
    Idris, Tagwa
    Shpall, Elizabeth J.
    Rezvani, Katy
    Colen, Rivka
    Zaky, Wafik
    Lee, Dean A.
    Gopalakrishnan, Vidya
    NEURO-ONCOLOGY, 2020, 22 (08) : 1214 - 1225
  • [6] Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19
    Ahmadvand, Mohammad
    Barough, Mahdieh Shokrollahi
    Hashemi, Zahra Sadat
    Sanati, Hassan
    Abbasvandi, Fereshteh
    Yunesian, Masud
    Majidzadeh, Keivan A.
    Makarem, Jalil
    Aghayan, Hamid Reza
    Abedini, Atefeh
    Ghavamzadeh, Ardeshir
    Forooshani, Ramin Sarrami
    PILOT AND FEASIBILITY STUDIES, 2023, 9 (01)
  • [7] Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19
    Mohammad Ahmadvand
    Mahdieh Shokrollahi Barough
    Zahra Sadat Hashemi
    Hassan Sanati
    Fereshteh Abbasvandi
    Masud Yunesian
    Keivan Majidzadeh-A
    Jalil Makarem
    Hamid Reza Aghayan
    Atefeh Abedini
    Ardeshir Ghavamzadeh
    Ramin Sarrami Forooshani
    Pilot and Feasibility Studies, 9
  • [8] PHASE I STUDY OF FOURTH VENTRICLE INFUSIONS OF AUTOLOGOUS EX-VIVO EXPANDED NK CELLS IN CHILDREN WITH RECURRENT/REFRACTORY MALIGNANT POSTERIOR FOSSA TUMORS OF THE CENTRAL NERVOUS SYSTEM
    Khatua, Soumen
    Sandberg, David
    Ketonen, Leena
    Rytting, Michael
    Cooper, Laurence
    Moyes, Judy
    Gopalakrishnan, Vidya
    Johnson, Jason
    Lee, Dean
    Liu, Diane
    Zaky, Wafik
    NEURO-ONCOLOGY, 2016, 18 : 24 - 24
  • [9] Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML
    Ciurea, Stefan O.
    Kongtim, Piyanuch
    Srour, Samer
    Chen, Julianne
    Soebbing, Doris
    Shpall, Elizabeth
    Rezvani, Katayoun
    Nakkula, Robin
    Thakkar, Aarohi
    Troy, Ella C.
    Cash, Alex A.
    Behbehani, Gregory
    Cao, Kai
    Schafer, Jolie
    Champlin, Richard E.
    Lee, Dean A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (05) : 890 - 899
  • [10] A Phase 1 Study of the Combination of MG4101, Ex Vivo-Expanded Allogeneic NK Cells and Rituximab for Relapsed or Refractory Non-Hodgkin Lymphoma
    Yoon, Dok Hyun
    Koh, Youngil
    Park, Heesook
    Hwang, Yu Kyeong
    Kim, Won Seog
    BLOOD, 2020, 136
12